Mohammed Al‐Nazawi

817 total citations
12 papers, 575 citations indexed

About

Mohammed Al‐Nazawi is a scholar working on Infectious Diseases, Molecular Biology and Pharmacology. According to data from OpenAlex, Mohammed Al‐Nazawi has authored 12 papers receiving a total of 575 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Infectious Diseases, 4 papers in Molecular Biology and 3 papers in Pharmacology. Recurrent topics in Mohammed Al‐Nazawi's work include SARS-CoV-2 and COVID-19 Research (4 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers) and Computational Drug Discovery Methods (2 papers). Mohammed Al‐Nazawi is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (4 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers) and Computational Drug Discovery Methods (2 papers). Mohammed Al‐Nazawi collaborates with scholars based in Saudi Arabia, Egypt and Japan. Mohammed Al‐Nazawi's co-authors include Mahmoud Kandeel, Abdelazim Ibrahim, Mahmoud Fayez, Abdulla Al‐Taher, Byoung Kwon Park, Hyung‐Joo Kwon, Abdullah I. A. Al-Mubarak, Abdullah Sheikh, Kentaro Oh‐hashi and Jun‐ichiro Inoue and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Life Sciences.

In The Last Decade

Mohammed Al‐Nazawi

12 papers receiving 561 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mohammed Al‐Nazawi Saudi Arabia 7 337 182 166 64 33 12 575
Shashikant Ray India 12 237 0.7× 136 0.7× 200 1.2× 38 0.6× 60 1.8× 21 540
Nishant Shekhar India 13 436 1.3× 190 1.0× 172 1.0× 63 1.0× 117 3.5× 30 710
Jin Soo Shin South Korea 14 311 0.9× 82 0.5× 186 1.1× 91 1.4× 21 0.6× 32 797
Haozhou Tan United States 13 427 1.3× 339 1.9× 229 1.4× 142 2.2× 26 0.8× 27 700
Mathieu Gendrot France 12 204 0.6× 130 0.7× 89 0.5× 71 1.1× 30 0.9× 32 555
Yongxia Shi China 11 338 1.0× 71 0.4× 358 2.2× 20 0.3× 91 2.8× 33 980
Soonju Park South Korea 8 377 1.1× 116 0.6× 121 0.7× 23 0.4× 51 1.5× 10 573
Kui Zheng China 10 397 1.2× 69 0.4× 181 1.1× 13 0.2× 90 2.7× 30 913
Vimal K. Maurya India 12 424 1.3× 68 0.4× 250 1.5× 24 0.4× 62 1.9× 26 877
Clara Rolland France 9 327 1.0× 78 0.4× 76 0.5× 22 0.3× 85 2.6× 18 557

Countries citing papers authored by Mohammed Al‐Nazawi

Since Specialization
Citations

This map shows the geographic impact of Mohammed Al‐Nazawi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammed Al‐Nazawi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammed Al‐Nazawi more than expected).

Fields of papers citing papers by Mohammed Al‐Nazawi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohammed Al‐Nazawi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammed Al‐Nazawi. The network helps show where Mohammed Al‐Nazawi may publish in the future.

Co-authorship network of co-authors of Mohammed Al‐Nazawi

This figure shows the co-authorship network connecting the top 25 collaborators of Mohammed Al‐Nazawi. A scholar is included among the top collaborators of Mohammed Al‐Nazawi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohammed Al‐Nazawi. Mohammed Al‐Nazawi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Kandeel, Mahmoud, Byoung Kwon Park, Mohamed A. Morsy, et al.. (2021). Virtual Screening and Inhibition of Middle East Respiratory Syndrome Coronavirus Replication by Targeting Papain-like Protease. SHILAP Revista de lepidopterología. 3(4). 179–187. 10 indexed citations
2.
Kandeel, Mahmoud & Mohammed Al‐Nazawi. (2020). Virtual screening and repurposing of FDA approved drugs against COVID-19 main protease. Life Sciences. 251. 117627–117627. 294 indexed citations
3.
Sheikh, Abdullah, Abdulla Al‐Taher, Mohammed Al‐Nazawi, Abdullah I. A. Al-Mubarak, & Mahmoud Kandeel. (2020). Analysis of preferred codon usage in the coronavirus N genes and their implications for genome evolution and vaccine design. Journal of Virological Methods. 277. 113806–113806. 52 indexed citations
4.
Kandeel, Mahmoud, Mizuki Yamamoto, Abdulla Al‐Taher, et al.. (2020). Small Molecule Inhibitors of Middle East Respiratory Syndrome Coronavirus Fusion by Targeting Cavities on Heptad Repeat Trimers. Biomolecules & Therapeutics. 28(4). 311–319. 19 indexed citations
5.
Kandeel, Mahmoud, et al.. (2020). A pilot study on the pharmacokinetics of a single intramuscular injection of cefquinome in Arabian camel calves. Acta Veterinaria Hungarica. 68(1). 59–64. 1 indexed citations
6.
Kandeel, Mahmoud, Abdulla Al‐Taher, Byoung Kwon Park, Hyung‐Joo Kwon, & Mohammed Al‐Nazawi. (2020). A pilot study of the antiviral activity of anionic and cationic polyamidoamine dendrimers against the Middle East respiratory syndrome coronavirus. Journal of Medical Virology. 92(9). 1665–1670. 42 indexed citations
7.
Kandeel, Mahmoud, Abdelazim Ibrahim, Mahmoud Fayez, & Mohammed Al‐Nazawi. (2020). From SARS and MERS CoVs to SARS‐CoV‐2: Moving toward more biased codon usage in viral structural and nonstructural genes. Journal of Medical Virology. 92(6). 660–666. 135 indexed citations
8.
Kandeel, Mahmoud, Yukio Kitade, Abdulla Al‐Taher, & Mohammed Al‐Nazawi. (2019). The structural basis of unique substrate recognition by Plasmodium thymidylate kinase: Molecular dynamics simulation and inhibitory studies. PLoS ONE. 14(2). e0212065–e0212065. 5 indexed citations
9.
Kandeel, Mahmoud, et al.. (2019). Cefotaxime pharmacokinetics in Arabian camel (Camelus dromedarius) calves after single intravenous injection. Tropical Animal Health and Production. 52(2). 887–891. 3 indexed citations
10.
Al‐Nazawi, Mohammed. (2014). Effect of enrofloxacin on hepatic microsomal mixed function oxidases in camel. Journal of Camel Practice and Research. 21(2). 173–173. 3 indexed citations
11.
Al‐Nazawi, Mohammed. (2008). Effects of enrofloxacin and marbofloxacin administration on some fertility parameters of male chicken. Journal of Taibah University for Science. 1(1). 1–4. 6 indexed citations
12.
Al‐Nazawi, Mohammed. (2003). COMPARATIVE PHARMACOKINETIC STUDIES ON OXYTETRACYCLINE IN CAMELS, SHEEP AND GOATS. SHILAP Revista de lepidopterología. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shashikant Ray Breakdown of academic impact, for papers by Nishant Shekhar Breakdown of academic impact, for papers by Jin Soo Shin Breakdown of academic impact, for papers by Haozhou Tan Breakdown of academic impact, for papers by Mathieu Gendrot Breakdown of academic impact, for papers by Yongxia Shi Breakdown of academic impact, for papers by Soonju Park Breakdown of academic impact, for papers by Kui Zheng Breakdown of academic impact, for papers by Vimal K. Maurya Breakdown of academic impact, for papers by Clara Rolland
Rankless by CCL
2026